Medexus Inc
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 0
- 0 authorized now
- Natural health products
- 0
- 0 active licences
- Medical device licences
- 0
- 0 active
- Notices of Compliance
- 19
Notices of Compliance
Newest first.
- METOJECT SUBCUTANEOUSMarch 30, 2023 · NOC 30419 · Supplement to a New Drug Submission (SNDS)
- RUPALLFebruary 2, 2023 · NOC 30035 · New Drug Submission (NDS)
- OTIXALJanuary 25, 2023 · NOC 29981 · New Drug Submission (NDS)
- PEDIAPHARM NAPROXEN SUSPENSIONDecember 20, 2022 · NOC 29738 · New Drug Submission (NDS)
- CUVPOSANovember 1, 2022 · NOC 29358 · New Drug Submission (NDS)
- TRISPANMay 17, 2022 · NOC 28200 · Supplement to a New Drug Submission (SNDS)
- METOJECT SUBCUTANEOUSDecember 7, 2021 · NOC 27184 · Supplement to a New Drug Submission (SNDS)
- TRECONDYVJune 25, 2021 · NOC 26154 · New Drug Submission (NDS)
- METOJECT SUBCUTANEOUSOctober 23, 2020 · NOC 24491 · Supplement to a New Drug Submission (SNDS)
- GLEOLANSeptember 9, 2020 · NOC 24192 · New Drug Submission (NDS)
- TRISPANAugust 27, 2020 · NOC 24131 · Supplement to a New Drug Submission (SNDS)
- METOJECTMay 22, 2020 · NOC 23661 · Supplement to an Abbreviated New Drug Submission (SANDS)
- METOJECT SUBCUTANEOUSAugust 16, 2018 · NOC 21229 · Supplement to a New Drug Submission (SNDS)
- TRIAMCINOLONE HEXACETONIDE INJECTABLE SUSPENSIONApril 19, 2018 · NOC 20763 · Supplement to a New Drug Submission (SNDS)
- METOJECT SUBCUTANEOUSJanuary 3, 2018 · NOC 20232 · Supplement to a New Drug Submission (SNDS)
- TRIAMCINOLONE HEXACETONIDE INJECTABLE SUSPENSIONDecember 12, 2017 · NOC 20144 · New Drug Submission (NDS)
- METOJECT SUBCUTANEOUSMay 17, 2016 · NOC 18099 · New Drug Submission (NDS)
- METOJECTDecember 22, 2008 · NOC 9959 · Supplement to an Abbreviated New Drug Submission (SANDS)
- METOJECTJanuary 11, 2008 · NOC 9292 · Abbreviated New Drug Submission (ANDS)